Viewing Study NCT06474468


Ignite Creation Date: 2025-12-24 @ 5:33 PM
Ignite Modification Date: 2026-02-12 @ 6:11 PM
Study NCT ID: NCT06474468
Status: RECRUITING
Last Update Posted: 2025-01-03
First Post: 2024-06-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Esophageal Cancer
Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module